US FDA, EMEA to consider new biomarker data for drug safety assessments News item 02 February 2013 Pages: 20 - 20
`Undesirable' lipid levels linked to HRT-related coronary events News item 02 February 2013 Pages: 21 - 21
Antipsoriatic effect of methotrexate reduced by concomitant folic acid News item 02 February 2013 Pages: 21 - 21
USP committee classifies green tea extracts as safety class 2 products Review 02 February 2013 Pages: 21 - 21
Solifenacin use not associated with increased HR or BP Incidence study 02 February 2013 Pages: 22 - 22
Tentative approval for generic irbesartan/hydrochlorothiazide issued by US FDA. Media release 02 February 2013 Pages: 22 - 22